September 2018 DAIT Council-Approved Concepts

Concepts represent early planning stages for program announcements, requests for applications, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.

NB: Council approval does not guarantee that a concept will become an initiative.

Table of Contents

Fc-Dependent Mechanisms of Antibody-Mediated Killing

For the published program announcement, see the October 5, 2018 Guide announcement, Fc-Dependent Mechanisms of Antibody-Mediated Killing (R21 Clinical Trial Not Allowed). For the published request for applications, see the October 5, 2018 Guide announcement, Fc-Dependent Mechanisms of Antibody-Mediated Killing (U01 Clinical Trial Not Allowed).

Processing and Presentation of Non-Conventional MHC Ligands

For the published program announcements, see the November 13, 2018 Guide announcements:

Computational Models in Immunity

For the published request for applications, see the January 30, 2019 Guide announcement, Computational Models of Immunity (U01 Clinical Trial Not Allowed).

Molecular and Genetic Characterization of Inborn Errors of Immunity

For the published program announcements with special receipt, referral, or review considerations, see the November 26, 2018 Guide announcements:

Development of Radiation/Nuclear Medical Countermeasures (MCMs)

For the published broad agency announcement, see the February 22, 2019 solicitation, 2019 NIAID Omnibus Broad Agency Announcement.

Informatics Methodology and Secondary Analyses To Explore Shared Immunology Study Data in ImmPort

For the published program announcement with special receipt, referral, or review considerations, see the March 22, 2019 Guide announcement, Informatics Methodology and Secondary Analyses for Immunology Data in ImmPort (UH2 Clinical Trial Not Allowed).

 
Content last reviewed on